Announcements Trials

Browse Landscape

Phase

Phase 3 5 Phase 4 3 Phase 2 3 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

Paclitaxel 9 Magnetic Resonance Spectroscopy 8 Cyclophosphamide 8 Cisplatin 8 Carboplatin 8 Granulocyte Colony-Stimulating Factor 7 Etoposide 7 Radiotherapy, Intensity-Modulated 6 Nivolumab 6 Leucovorin 6 Filgrastim 6 Drug Therapy 6 Doxorubicin 6 Radiotherapy 5 Oxaliplatin 5 Fluorouracil 5 Docetaxel 5 Bevacizumab 5 pembrolizumab 4 gallium 68 PSMA-11 4 Taxes 4 Sirolimus 4 Rituximab 4 Pemetrexed 4 Melphalan 4 Immunoglobulin G 4 Gemcitabine 4 Disulfides 4 Dexamethasone 4 Cytarabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Has results × lanreotide × Clear all

NCT02288377 2023-01-18

REMINET

Federation Francophone de Cancerologie Digestive

Phase 2/3 Terminated

53 enrolled 11 charts

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡